Predictions of a sales-growth slowdown sent DexCom stock tumbling this summer. Management predicted third-quarter sales would rise by just 1% to 3% year over year. Two of DexCom's top competitors ...
The bull case for DexCom is that the company continues to grow and has a lot of room to grow more. The bear case for the stock is that DexCom's sky-high valuation may be hard to justify in the long ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM) (“Dexcom”) announced today that it intends to offer, subject to market conditions and other factors, $1.0 billion aggregate principal amount of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback